bluebird bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
bluebird bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $0 as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2025-03-27
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $11.00K.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $380.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-27 |
| 2023-12-31 | $0.00 10-K · filed 2024-09-13 |
| 2022-12-31 | $11.00K 10-K · filed 2023-03-29 |
| 2021-12-31 | $380.00K 10-K · filed 2022-03-04 |
| 2020-12-31 | $15.66M 10-K · filed 2021-02-23 |
| 2019-12-31 | $64.90M 10-K · filed 2020-02-18 |
| 2018-12-31 | $90.78M 10-K · filed 2019-02-21 |
| 2017-12-31 | $234.19M 10-K · filed 2018-02-21 |
| 2016-12-31 | $70.99M 10-K · filed 2017-02-22 |
| 2015-12-31 | $61.16M 10-K · filed 2016-02-25 |
| 2014-12-31 | $109.28M 10-K · filed 2015-02-25 |
| 2013-12-31 | $24.52M 10-K · filed 2014-03-05 |